Cleared Special

K202797 - Drakon and Sequre Microcatheters (FDA 510(k) Clearance)

Oct 2020
Decision
30d
Days
Class 2
Risk

K202797 is an FDA 510(k) clearance for the Drakon and Sequre Microcatheters. This device is classified as a Catheter, Intravascular, Diagnostic (Class II - Special Controls, product code DQO).

Submitted by Accurate Medical Therapeutics, Ltd. (Rehovot, IL). The FDA issued a Cleared decision on October 23, 2020, 30 days after receiving the submission on September 23, 2020.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1200.

Submission Details

510(k) Number K202797 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2020
Decision Date October 23, 2020
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQO - Catheter, Intravascular, Diagnostic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1200